Polychemotherapy
Showing 1 - 25 of 71
Cardiotoxicity Trial in Moscow (Remote 1-minute single-lead electrocardiogram (ECG) monitoring in cancer patients after the
Recruiting
- Cardiotoxicity
- Remote 1-minute single-lead electrocardiogram (ECG) monitoring in cancer patients after the first polychemotherapy cycle.
-
Moscow, Russian FederationI.M. Sechenov First Moscow State Medical University (Sechenov Un
Jan 7, 2023
Newly Diagnosed Type 2 Diabetes Trial in Parma (Metformin-Sitagliptin-Empaglifozin-Pioglitazone, Standard of care)
Recruiting
- Newly Diagnosed Type 2 Diabetes
- Metformin-Sitagliptin-Empaglifozin-Pioglitazone
- Standard of care
-
Parma, ItalyAzienda Ospedaliero Universitaria di Parma
Aug 10, 2021
Platinum-based Cancer Treatment on Endothelial Function
Completed
- High Blood Pressure
- Cardiovascular Complication
-
Moscow, Russian Federation
- +1 more
Dec 18, 2020
Acute Lymphoblastic Leukemia, in Relapse Trial in Belgium, France (GRASPA, L-asparaginase)
Completed
- Acute Lymphoblastic Leukemia, in Relapse
-
Bruxelles, Belgium
- +27 more
Feb 1, 2022
Perioperative Chemotherapy in Gastric Cancer
Completed
- Gastric Cancer
- epirubicin + cisplatin + capecitabine polychemotherapy
-
Santiago, RM, ChileInstituto Nacional del Cáncer
Apr 21, 2020
Acute Myeloid Leukemia, Adult, Cardiotoxicity, Endothelial Dysfunction Trial in Samara (History taking, Anthropometry, Complete
Recruiting
- Acute Myeloid Leukemia, Adult
- +2 more
- History taking
- +14 more
-
Samara, Samara Region, Russian FederationClinics of the Samara Medical University
Jan 26, 2023
Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response
Recruiting
- Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB
- Vacuum-assisted biopsy
-
Saint-Petersburg, Russian FederationPetr Krivorotko
Jun 14, 2022
CNS Lymphoma Trial in Aarhus (Immunochemo)
Completed
- Central Nervous System Lymphoma
-
Aarhus, DenmarkElisa Jacobsen Pulczynski
Aug 3, 2022
T-cell-prolymphocytic Leukemia Trial in Cologne (Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab, Alemtuzumab)
Completed
- T-cell-prolymphocytic Leukemia
- Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab
- Alemtuzumab
-
Cologne, GermanyUniversity Hospital Cologne
Dec 16, 2021
Primary CNS Lymphoma Trial in Paris (Rituximab, Methotrexate, Temozolomide)
Active, not recruiting
- Primary Central Nervous System Lymphoma
- Rituximab, Methotrexate, Temozolomide
-
Paris, FranceGroupe Hospitalier Pitie Salpetriere
Feb 10, 2022
Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)
Not yet recruiting
- Triple Negative Breast Cancer
- Sacituzumab govitecan
- Pembrolizumab
- (no location specified)
Oct 5, 2023
Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)
Not yet recruiting
- Malignant Pleural Mesothelioma
- Gemcitabine
- supportive care
-
Cairo, EgyptAin Shams University Hospital
Dec 20, 2022
Primary CNS Lymphoma Trial in Paris ([18F]-FDG PET/MR)
Active, not recruiting
- Primary Central Nervous System Lymphoma
- [18F]-FDG PET/MR
-
Paris, FrancePitié Salpêtrière Hospital
Sep 9, 2021
Lymphoblastic Lymphoma Trial in Chengdu, Shanghai (Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide,
Active, not recruiting
- Lymphoblastic Lymphoma
- Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine
- +6 more
-
Chengdu, China
- +1 more
Mar 17, 2022
Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Gastric
Completed
- Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction
- +5 more
- S-1 de-escalation
- Chemotherapy by Investigator's choice
-
Heidelberg, Baden-Württemberg, GermanyNCT-Med. Onkologie
Mar 25, 2021
Acute Lymphoblastic Leukemia Trial in France (suspension of erythrocytes encapsulating L-asparaginase)
No longer available
- Acute Lymphoblastic Leukemia
- suspension of erythrocytes encapsulating L-asparaginase
-
Besançon, France
- +9 more
Nov 30, 2018
T-cell Lymphoblastic Lymphoma Trial in Shanghai, Chengdu (Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine,
Not yet recruiting
- T-cell Lymphoblastic Lymphoma
- Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin
- Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide
-
Shanghai, Shanghai, China
- +1 more
Dec 27, 2022
Primary CNS Lymphoma Trial in Worldwide (Rituximab, Methotrexate, Procarbazine)
Recruiting
- Primary Central Nervous System Lymphoma
- Rituximab
- +5 more
-
Aarhus, Denmark
- +34 more
Nov 4, 2022
Gestational Trophoblastic Neoplasias (GTN) Trial in France (Avelumab administration at 10mg/kg)
Completed
- Gestational Trophoblastic Neoplasias (GTN)
- Avelumab administration at 10mg/kg
-
Bordeaux, France
- +5 more
Sep 1, 2021
Effect of Drug, Toxicity, Drug, Secondary Resistance Trial in Beijing (Apatinib Mesylate, ifosfamide and etoposide)
Completed
- Effect of Drug
- +2 more
- Apatinib Mesylate
- ifosfamide and etoposide
-
Beijing, Beijing, ChinaPeking University People's Hospital
Mar 12, 2022
Metastatic Pancreatic Cancer Trial in France, Martinique (Irinotecan Liposomal Injection, 5-FU/LV, Nab-Paclitaxel)
Recruiting
- Metastatic Pancreatic Cancer
- Irinotecan Liposomal Injection
- +3 more
-
Amiens, France
- +35 more
Mar 23, 2022